Avatrombopag
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 222 publications
Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: April 14, 2026
Single-cell transcriptome deciphers key targets of thrombopoietin receptor agonists and immune microenvironment characteristics of immune thrombocytopenia.
Journal: Platelets
Published: April 01, 2026
Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.
Journal: Expert opinion on pharmacotherapy
Published: March 24, 2026
Avatrombopag and Platelet Recovery in Sepsis-Associated Thrombocytopenia: A Retrospective Observational Cohort Study.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 13, 2026
Refractory Primary Immune Thrombocytopenia With Bleeding and Thrombosis: A Case Report.
Journal: The American journal of case reports
Published: February 15, 2026
Real-World Safety and Efficacy of Avatrombopag in Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.
Journal: European journal of haematology
Published: January 15, 2026
Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.
Journal: Journal of clinical medicine
Published: January 12, 2026
Integrated Assessment of Three NDSRIs Through CPCA Prioritization, In Silico Toxicity Assessment, and Stability Indicating LC-MS/MS Method for Avatrombopag Maleate.
Journal: Biomedical chromatography : BMC
Published: January 09, 2026
Pulmonary Embolism and Myocardial Infarction With Non-obstructive Coronary Arteries in Immune Thrombocytopenia: Unmasking Underlying Antiphospholipid Syndrome.
Journal: Cureus
Published: January 04, 2026
Comment on "The application of avatrombopag in chronic liver disease patients with severe thrombocytopenia undergoing procedures in China: a prospective real-world cohort study".
Journal: International journal of surgery (London, England)
Published: December 21, 2025
Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary.
Journal: Expert review of hematology
Published: December 18, 2025
Cost-effectiveness of hetrombopag, eltrombopag, and avatrombopag for chronic immune thrombocytopenia in China: a cost-utility analysis.
Journal: Frontiers in public health
Published: December 09, 2025
Last Updated: 04/28/2026